1. Home
  2. FOSL vs GALT Comparison

FOSL vs GALT Comparison

Compare FOSL & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$4.02

Market Cap

208.1M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.82

Market Cap

199.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
GALT
Founded
1984
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
199.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FOSL
GALT
Price
$4.02
$2.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$8.50
AVG Volume (30 Days)
870.5K
338.8K
Earning Date
03-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$1.15
52 Week High
$5.01
$7.13

Technical Indicators

Market Signals
Indicator
FOSL
GALT
Relative Strength Index (RSI) 45.16 43.36
Support Level $3.25 $2.59
Resistance Level $4.23 $3.32
Average True Range (ATR) 0.34 0.23
MACD -0.07 -0.02
Stochastic Oscillator 21.43 21.43

Price Performance

Historical Comparison
FOSL
GALT

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: